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Mutations associated with Dent’s
disease affect gating and voltage
dependence of the human
anion/proton exchanger ClC-5
Alexi K. Alekov*
Institut für Neurophysiologie, Medizinische Hochschule Hannover, Hannover, Germany
Dent’s disease is associated with impaired renal endocytosis and endosomal
acidification. It is linked to mutations in the membrane chloride/proton exchanger ClC-5;
however, a direct link between localization in the protein and functional phenotype of
the mutants has not been established until now. Here, two Dent’s disease mutations,
G212A and E267A, were investigated using heterologous expression in HEK293T cells,
patch-clamp measurements and confocal imaging. WT and mutant ClC-5 exhibited
mixed cell membrane and vesicular distribution. Reduced ion currents were measured for
both mutants and both exhibited reduced capability to support endosomal acidification.
Functionally, mutation G212A was capable of mediating anion/proton antiport but
dramatically shifted the activation of ClC-5 toward more depolarized potentials. The shift
can be explained by impeded movements of the neighboring gating glutamate Gluext,
a residue that confers major part of the voltage dependence of ClC-5 and serves as a
gate at the extracellular entrance of the anion transport pathway. Cell surface abundance
of E267A was reduced by ∼50% but also dramatically increased gating currents were
detected for this mutant and accordingly reduced probability to undergoing cycles
associated with electrogenic ion transport. Structurally, the gating alternations correlate
to the proximity of E267A to the proton glutamate Gluin that serves as intracellular
gate in the proton transport pathway and regulates the open probability of ClC-5.
Remarkably, two other mammalian isoforms, ClC-3 and ClC-4, also differ from ClC-5 in
gating characteristics affected by the here investigated disease-causing mutations. This
evolutionary specialization, together with the functional defects arising from mutations
G212A and E267A, demonstrate that the complex gating behavior exhibited by most of
the mammalian CLC transporters is an important determinant of their cellular function.
Keywords: Dent’s disease, ClC transport, ClC-5, non-linear capacitance, gating currents, vesicular acidification,
endocytosis, voltage dependence
Introduction
Dent’s disease (Dent and Friedman, 1964) is a X-linked hereditary disease coupled to impaired
function of the kidney. The pathophysiology of the disease has been connected to mutations
in two different genes – CLCN5 and OCRL1 (Lloyd et al., 1996; Hoopes et al., 2005). OCRL1
encodes a Golgi-localized PI(4,5)P2 5-phosphatase that interacts with clathrin and regulates
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protein trafficking between endosomes and the Golgi network
(Suchy et al., 1995; Zhang et al., 1995; Choudhury et al.,
2005). The second gene, CLCN5, encodes for the membrane
transporter ClC-5 that resides in endocytotic vesicles (Günther
et al., 1998; Sakamoto et al., 1999) and mediates secondary
active chloride/proton exchange (Picollo and Pusch, 2005; Scheel
et al., 2005). Knockout of Clcn5 in mice is associated with
impaired renal endocytosis and significantly slowed rates of
endosomal acidification (Piwon et al., 2000; Günther et al.,
2003). Similar effects have been observed in conditionally
immortalized proximal–tubular epithelial cell lines derived
from Dent’s disease patients carrying ClC-5 mutations (Gorvin
et al., 2013). Recent investigations suggest that ClC-5 might
be also involved in the regulation of intraendosomal chloride
concentration (Novarino et al., 2010). Impaired endocytosis and
endosomal ion homeostasis seem therefore to represent the
major mechanisms leading to Dent’s disease.
The clear association between genetic alternations in CLCN5
and Dent’s disease has motivated numerous investigations of
the molecular mechanisms underlying the renal pathophysiology
observed in the affected patients. The functional consequences
of the majority of the currently mapped mutations have been
already described. Surprisingly, the data suggest the existence
of very significant phenotypic heterogeneity with one aspect of
this heterogeneity appearing especially interesting. In particular,
most of the mutants (class 1 mutants) have been found to induce
a trafficking defect to the plasma membrane which reduces
the electrogenic transport mediated by ClC-5 as detected by
electrophysiology (Ludwig et al., 2005; Smith et al., 2008; Grand
et al., 2009, 2011). However, a distinct subclass of mutants
have been also described for which ion transport is strongly
reduced or even completely abolished despite the significant
number of ClC-5 proteins present in the plasma membrane.
The molecular mechanisms underlying this behavior have not
been revealed yet; however, the complex nature of the CLC
transporter operation allows several possible explanations (Smith
et al., 2008; Grand et al., 2009, 2011; Lourdel et al., 2012).
For example, the corresponding mutations could block the
ion permeation pathway, alter the transporter selectivity and
substrate coupling or reduce unitary transport rates of ClC-5.
In this regard, prominent voltage-dependent gating has been
described as a hallmark feature exhibited by most of the
mammalian CLC isoforms (Alekov and Fahlke, 2009; Smith
and Lippiat, 2010; Orhan et al., 2011; Grieschat and Alekov,
2012; Guzman et al., 2013; Stefano et al., 2013). It is well-
established that altered voltage-dependent gating plays a major
role for the pathophysiology of various hereditary diseases
associated with members of the “channel branch” of the CLC
family. It appears therefore very likely that analogous effects
might be involved in the development of Dent’s disease and
that alternations of the voltage dependence of ClC-5 might be
responsible and explain the reduced current amplitudes observed
in this particular subclass of mutants for which no change in
surface expression is detected. Here, this hypothesis is tested by
investigating the functional consequences of two point mutations
that have been previously associated with Dent’s disease by
genetic analysis. The first one, G212A, has been shown to reduce
ClC-5 current amplitudes without altering its surface abundance
(Grand et al., 2009). The choice of this particular mutation was
motivated by its close proximity to the so-called gating glutamate
E211 that is crucial for voltage-dependent gating of both CLC
channels and transporters (Gluext, Figure 1) (Dutzler et al., 2003).
It appears therefore possible that G212A might affect ClC-5
voltage sensing and lead in this way to reduced CLC transport.
For the second Dent’s mutation, E267A (Hoopes et al., 2004),
no functional investigations have been published until now.
Similarly to G212A, mutation E267A is close to a residue that
plays an important role in the CLC transport cycle. In particular,
it is next to the so called proton glutamate E268 (Gluin) that
serves as a gate for protons from the intracellular side of the CLC
protein (Accardi et al., 2005) and defines the apparent transport
probability of ClC-5 by regulating proton injection into the
ClC gating machinery (Grieschat and Alekov, 2012). Strikingly,
some of the CLCs do not have a glutamate at the corresponding
position, i.e., they lack the proton glutamate Gluin but are still
capable of transporting protons in exchange for chloride. It was
therefore hypothesized that the neighboring glutamate which
corresponds to the Dent’s E267 in ClC-5 (Figure 1) might take
over the role of Gluin and enable coupled anion/proton in these
isoforms (Feng et al., 2010; Phillips et al., 2012). The role of
glutamate E267 in the mammalian transporter isoforms has not
been investigated until now; however, it appears feasible that this
residue and accordingly the molecular mechanisms underlying
the pathophysiology of the Dent’s disease mutation E267A might
be also coupled to proton transport in ClC-5.
Materials and Methods
Constructs and Functional Expression
The construction of the pRcCMV vector containing the DNA
encoding for human ClC-5 with the fluorescent protein mCherry
fused to its C-terminus was described previously in detail
(Grieschat and Alekov, 2012). The YFP fusion used in some
of the experiments was also created previously in an identical
manner. The Dent’s disease mutations were introduced into
the mCherry-containing construct using QuikChange site-
directed mutagenesis (Agilent) and verified by sequencing. An
extracellular haemagglutinin (HA)-tag was inserted into the
mCherry construct in the ClC-5 sequence between amino acids
392 and 393. This position is predicted to be situated at one of
the long extracellular loops in mammalian CLCs and was used
previously to assess the surface expression of ClC-2 (Garcia-
Olivares et al., 2008). The synapto-pHluorin2 construct was
a gift from Dr. Guzman and was created by replacing the
pHluorin in the original synapto-pHluorin, kindly provided
by Dr. Miesenböck (Miesenböck et al., 1998), for the brighter
pHluorin2 (Mahon, 2011) that was a gift from Dr. Mahon, and
subcloning the resulting fusion construct into the p156rrL vector
using standard PCR procedures. mRFP-Rab5 was a gift from Ari
Helenius (Addgene plasmid # 14437) (Vonderheit and Helenius,
2005). HEK 293T cells used for the experiments were cultured
in DMEM (Gibco) supplemented with 10% FBS (Biochrom
AG), 2mM L-glutamine and 50 units/ml penicillin/streptomycin
(Invitrogen). When required, cells were transfected using the
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FIGURE 1 | Structural localization and evolutionary conservation of
two Dent’s disease associated mutations. (A) Ribbon representation of
the dimeric biological assembly typical for proteins of the CLC family and
based on the crystal structure of the eukaryotic CmCLC (PDB id: 3ORG). Two
identical monomers capable of mediating coupled chloride/proton exchange
are assembled to form a functional CLC dimer. Superimposed as arrows on
the right monomer are the anion and proton transport pathways, separated at
the bottom (intracellular) side and converging at the central anion biding site to
follow the same exit/entry pathway toward the top of the protein. The two here
investigated Dent’s disease mutations are localized at key positions along
these pathways—mutation G212A is located at the top of the protein at the
separate exit for anions and protons; mutation E267A is localized at the
intracellular entrance of the proton transport pathway. (B) Enlarged view of the
protein regions surrounding mutations G212A and E267A with additionally
annotated the gating [Gluext – indicated with a star here and in the sequence
alignment in (C)] and proton [Gluin – indicated with two stars here and in the
sequence alignment in (C)] glutamates that both play decisive roles for the
CLC transport cycle. (C) Sequence conservation of the regions surrounding
both investigated Dent’s disease mutations. The glycine G212 is an amino acid
that is conserved throughout the mammalian CLC isoforms and precedes the
gating glutamate Gluext. Glutamate E267 is also well-conserved and precedes
the proton glutamate E268 in the sequence of ClC-5.
calcium phosphate precipitation method (Graham and van der
Eb, 1973).
Electrophysiology
Electrophysiology was performed as previously described in
detail (Grieschat and Alekov, 2012). In brief, EPC-10 amplifier,
controlled by the PATCHMASTER software package (both from
HEKA Electronics), was used to perform whole-cell patch-
clamp (Hamill et al., 1981) with currents being recorded after
filtering at 3 kHz and digitalization at 100 kHz sampling rate. To
reduce the associated voltage errors, capacitance cancelation and
series resistance compensation were applied and recordings for
which the uncompensated error exceeded 5mV were discarded.
Patch pipettes with resistances between 1 and 1.8M were
filled with a patch pipette solution containing (in mM) 110
NaCl, 5 MgCl2, 5 EGTA and 10 HEPES, pH 7.4. The standard
extracellular solution contained (in mM) 145 NaCl, 4 KCl, 2
CaCl2, 1 MgCl2, and 15 HEPES, pH 7.4. In some cases, P/4
leak subtraction (Armstrong and Bezanilla, 1974) was applied
from a holding potential of −60mV. Non-linear capacitances
were measured using the Lock-in extension of PATCHMASTER
(HEKA Electronics). In particular, the sine-plus-DC technique
(Gillis, 2000) was used with 10-mV sine waves with 400-Hz
frequency being superimposed on DC pulses of variable voltage.
When appropriate (for WT and mutation E267A ClC-5), non-
linear capacitances were fitted with the first derivative of a
standard Boltzmann function (Santos-Sacchi, 1991):
C(V) =
β Qmax e
−β (V0−V0.5)
(1 + e−β(V0−v0.5))
2
with β = z
(
e0 δ
kB
T
)
(1)
where Qmax denotes the maximum charge moved at the voltage
of half-maximal activation (V0.5), z represents the number
of elementary charges e0 displaced over a membrane fraction
(δ), kB is the Boltzmann constant and T is the absolute
temperature.
Confocal Imaging and Vesicular pH
Measurements
Images were acquired 24-48 h after transfection on a Carl-Zeiss
LSM 780 inverted microscope using a 40x water immersion
objective or on an ANDOR spinning disk imaging system
equipped with Yokogawa CSU-X1 unit using a 60x water
immersion objective. The pHluorin2 and mCherry fluorophores
were excited at 405/488 and 561 nm and emission was detected
at 500-550 and 560-650 nm, respectively. The fluorescence of
mRFP and YFP was excited by the 561-nm and the 514-nm
laser lines, respectively, and detected by an ANDOR IXON3
camera. For the colocalization analysis of Rab5-RFP and ClC-5-
YFP or synapto-pHluorin2, a CAIRNOptoSplit mage splitter was
used to separate the fluorescence of the individual fluorophores.
Cells were maintained during live cell imaging in PBS containing
Ca2+ and Mg2+ (GIBCO) at room temperature (22–24◦C). For
the calibration experiments, PBS was exchanged for potassium-
based solutions with different pHs and supplemented with
10µM nigericin. The analysis of the calibration data and
the assembly of the confocal images for publication were
performed using Carl Zeiss Zen lite 2011 (Blue edition) software.
Particle detection was performed using theMatLab (MathWorks)
adaptation by Blair and Dufresne of the original Crocker and
Grier algorithm (Crocker and Grier, 1996). The code was
incorporated into house-written MatLab software that carried
out the automatic background subtraction, segmentation using
the before-mentioned algorithm, and the subsequent ratiometric
analyses of the identified vesicular regions. The colocalization
between Rab5-RFP and ClC-5-YFP or synapto-pHluorin2 was
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determined using the standard colocalization analysis plugin of
IMAGEJ (Rasband, n.d.).
Relative Surface Expression of ClC-5
The relative surface expression of WT and mutant ClC-5 was
determined in cells transfected with HA-ClC-5 (see below)
using a slight modification of previously published methods
(Smith et al., 2008). In brief, the ClC-5 proteins localized
at the surface membrane were labeled in suspension at 4◦C
for 1 h with anti-HA antibodies targeting an extracellular HA
tag engineered in one of the predicted extracellular loops of
mammalian CLC proteins (Garcia-Olivares et al., 2008), washed
three times with cold PBS and subsequently labeled with anti-
mouse horseradish perioxidase (HRP)-conjugated antibodies (all
antibodies were obtained from Thermo Scientific). The amount
of cell-bound HRP was determined after additional extensive
washing by chemi-luminescence using a VICTOR3 plate reader
(PerkinElmer). To obtain the relative surface expression of
the investigated constructs, the HRP-coupled luminescence was
divided by the fluorescence of the C-terminal mCherry tag that
was excited at 488 nm and measured at 535 nm wavelength in the
same well and reported the total ClC-5 expression.
Fluorescence Measurements of Intracellular pH
Measurements of intracellular alkalinization as marker for the
CLC proton transport were described in detail elsewhere (Alekov
and Fahlke, 2009). In brief, cells were loaded with 37.5µM
2′,7′-bis(2-carboxyethyl)-5(and 6)-carboxyfluorescein (BCECF,
Wako Chemicals) through the patch pipette. The HEPES
content of the intracellular patch-clamp solution was reduced in
these experiments to 0.25mM in order to reduce its buffering
capacity. BCECF fluorescence was observed with an UPlanSApo
60x/NA1.35 oil immersion objective on an Olympus IX-71
microscope. Sequential excitation at 490 and 440 nm was applied
using a Polychrome V monochromator and the fluorescence was
detected at 530 nmwith a photodiode (both from Till Photonics).
The resultant fluorescence ratio F490/F440 was converted to
absolute pH by using a calibration curve, previously obtained ex
situ (see description in Grieschat and Alekov, 2012). The rate of
cytosolic alkalinization (1pH/1t) was obtained from linear fits
to the data and used as a value proportional to the proton flux of
ClC-5.
Data Analysis and Presentation
Data were analyzed by a combination of Excel (Microsoft),
Origin (MicroCal), and MatLab (MathWorks) and assembled
as publication figures in Origin. Differences were tested for
significance using two-sample t-test, all data are presented as
mean± SEM.
Results
Mutations G212A and E267A Provide Weaker
Support for Endosomal Acidification in HEK293T
Cells
The role of ClC-5 for endosomal acidification is well-established
and is of crucial importance for the proper function of the kidney
(Jentsch, 2008). The first step of the investigation of both disease
causing mutations was therefore to investigate their capacity to
support endosomal acidification. To this end, the ratiometric pH-
sensitive GFP variant pHluorin2 (Mahon, 2011) was fused to the
C-terminus of the vesicular protein VAMP-2/synaptobrevin in
analogy to the original synapto-pHluorin construct developed
for vesicular pH measurements (Miesenböck et al., 1998). In
this way, a pH-sensitive fluorophore with superior brightness
was targeted to the vesicular lumen. Synapto-pHluorin2 was
excited at two different wavelengths (405 and 488 nm) and
the fluorescence intensity at the 530-nm pHluorin2 emission
maximum was measured on a confocal microscope. 2D-imaging
was chosen for these investigation in order to reduce the
time lag between capturing the fluorescence excited at different
wavelengths and accordingly the spatial shift between the
different channels due to the motility of the endocytotic vesicles.
A calibration curve that compares the ratio of the fluorescence
excited at the two wavelengths (the ratio F488ex/F405ex) and the
absolute pH sensed by the fluorescent protein was constructed
by performing experiments in solution with different pH-s and
clamping the intracellular acidity with the H+/K+ exchanger
nigericin (Figures 2A–C). For these experiments, live cells that
exhibited strong plasma membrane localization of synapto-
pHluorin2 were chosen and exclusively defined membrane
regions were selected and analyzed (Figures 2A,B). At the next
step, the colocalization of ClC-5 and synapto-pHluorin2 was
demonstrated by coexpression with the endosomal small GTPase
Rab5 (Figures 2D,E). Finally, the pH of vesicles containing either
ClC-5 WT or the mutants G212A and E267A was measured by
automatic vesicle identification (Figures 2F–H) and ratiometric
fluorescence measurements. Live cells expressing both ClC-5 and
synapto-pHluorin2 were imaged sequentially at three different
wavelengths – 561 nm to excite the red mCherry attached to
ClC-5 and 488 and 405 nm to excite the different spectral
lines of pHluorin2 (Figure 2F). ClC-5-containing vesicles were
identified in the red channel by using automated spot detection
routines (Figure 2G) and the ratio F488ex/F405ex measured
in the so-defined circular regions was used to quantify
endosomal pH. The analysis revealed that expression of WT
ClC-5 leads to significantly stronger endosomal acidification in
HEK293T cells. In contrast, there was no difference between
cells expressing synapto-pHluorin2 alone or together with
either of both ClC-5 variants associated with Dent’s disease
(Figure 2H). The encountered significant differences suggest that
the capacity of ClC-5 to support endosomal acidification is
compromised by the here investigated disease-causing mutations
and provide the bases for understanding of the associated renal
pathophysiology.
Mutations G212A and E267A Exhibit Similar
Mixed Endosomal/Plasma Membrane
Localization and Different Transport Properties in
Comparison to WT ClC-5
The next step of the investigation of mutations G212A and
E267A ClC-5 was to describe their functional properties and
to establish a link between these and the encountered reduced
vesicular acidification. To this end, 3D confocal imaging was
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FIGURE 2 | Luminal pH in WT and disease-associated
ClC-5-containing endosomes. (A,B) Representative confocal images of
cells expressing synpto-pHluorin2 excited at 405 nm (A) and 488 nm (B)
and both detected at a wavelength of 530 nm. For the analysis,
membrane regions as depicted in (A) were selected and the fluorescence
intensity in both channels was measured. (C) Calibration curve
constructed from measurements as depicted in (A,B). The ratios were
obtained by taking confocal images from cells (n = 6 cells for each
experimental point) bathed in solutions with pH-s as indicated and
containing nigericin to equilibrate the extracellular and intracellular acidity.
The calibration curve was constructed by fitting a straight line to the data.
(D) Representative cellular distribution and map of the colocalizing pixels
for coexpressed Rab5-RFP and ClC-5-YFP expressed in HEK293T cells.
(E) Representative cellular distribution and map of the colocalizing pixels
for coexpressed Rab5-RFP and synapto-pHluorin2 expressed in HEK293T
cells. (F) Representative confocal images as used for determining
intravesicular pH. The large image represents the overlay of the
fluorescence using 560 nm laser line to excite the mCherry attached to
ClC-5 (red) and the 488-nm laser line to excite the synapto-pHluorin2
(green) molecules. Both channels are represented as small sub-images at
the right of the overlay; for simplicity, the 405-nm channel was not
depicted. (G) Illustration of the particle identification procedure used to
select individual vesicular regions in the red channel (ClC-5-containing
endosomes) and used to measure the fluorescence intensities in both
pHluorin2 channels. The identified particles are overlaid as circles on the
red channel of the cells depicted in (F). For measuring of endosomal pH
in cells not transfected with ClC-5, particle detection was performed
analogously using the florescence images taken in the blue channel
(405-nm excitation). (H) Average vesicular pH determined as depicted in
(F,G) for cells transfected with synapto-pHluorin2 only (mock, n = 7) or
cotransfected with synapto-pHluorin2 and either WT, G212A or E267A
ClC-5 (n = 18, 18, 9, respectively). First, the ratio of the intensities of the
blue and green channels (excitation at 405 and 488 nm, both detected at
530-nm wavelength) was calculated and this ratio was subsequently
converted to absolute pH using the calibration curve depicted in (C).
Significant differences at the level of 0.05 are indicated as stars.
performed first to investigate in further detail the cellular
distribution of both Dent’s mutations. The images showed that
all investigated constructs exhibit similar mixed localization
pattern. The majority of the ClC-5 proteins resided in vesicular
structures but also a significant plasma membrane localization
was evident (Figures 3A–C). This allowed performing in a
next step an electrophysiological characterization of the CLC
anion/proton exchange by whole-cell path-clamp. The well-
defined current trace families obtained upon voltage steps
between −115 and +175mV (Figures 3D–F) demonstrate that
both investigated mutants did not lose their ion transport
capability. However, despite the overall similarity to theWTClC-
5, these measurements revealed also that the mutants exhibit
significantly smaller transport current amplitudes. Moreover,
while both G212A and E267A exhibited prominent gating
currents (gating charge movements, see insets in Figures 3D–F),
their amplitudes in relation to the corresponding transport
currents strongly differed from the ones of WT ClC-5. The
gating currents of G212A were smaller than the one of WT
ClC-5 but mutation E267A exhibited the opposite behavior.
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FIGURE 3 | Cellular localization and transport of WT and
disease-associated ClC-5 mutants. (A–C) Confocal florescent images of
cells transfected with either WT or the mutants G212A and E267A ClC-5 with
fused mCherry at the C-terminus. Visible as bright fluorescent spots is the
strong vesicular localization but a significant percentage of the ClC-5 proteins
are also localized to the plasma membrane. (D–F) Current families recorded
from cells expressing the investigated constructs by whole-cell patch-clamp
upon voltage steps between −115 and +175mV. The insets depict enlarged
the off-gating currents for the corresponding mutant that have been used
subsequently for estimating the voltage-dependence of ClC-5 activation.
A summary of these observation is provided in Figure 5.
Since gating currents in ClC-5 reflect the existence of
incomplete silent transport cycles, i.e., conformational changes
that are not associated with electrogenic chloride/proton
exchange (Grieschat and Alekov, 2012), the encountered
differences suggest that the probability for completing the
transport cycle with ions being transported through the
membrane is altered by both here investigated Dent’s disease
mutations.
To quantify the relative surface expression of the mutants
and compare it with the encountered reduced ion transport,
they were introduced into a previously created construct
containing ClC-5 that was C-terminally tagged with mCherry
and an HA tag engineered in one of the predicted extracellular
loops of the protein. An insertion at the analogous position
in ClC-2 was previously successfully used to determine the
surface expression of this isoform (Garcia-Olivares et al.,
2008). Similarly to ClC-2, the introduced additional amino
acids did not alter the properties of ClC-5 (data not shown).
The relative number of ClC-5 localized to the plasma
membrane was determined by the binding of anti-HA antibodies
(surface marker), normalized to the mCherry intensity that
was used as a marker for the total ClC-5 expression. The
experiments confirmed the previously reported unchanged
surface expression of mutation G212A (Figure 4) (Grand
et al., 2009) but also showed a significantly lower (∼50%
compared to WT) plasma membrane localization for the E267A
mutation.
FIGURE 4 | Relative surface expression of WT and disease-associated
ClC-5 mutants. Ratio of the surface ClC-5 assessed by HRP
chemi-luminescence from an antibody targeting a HA tag engineered in one of
the extracellular ClC-5 loops (proportional to the surface expressed ClC-5) and
the fluorescence of the mCherry bound to the C-termini of the investigated
constructs (proportional to the total ClC-5 expression). The significant
difference between WT and E267 ClC-5 at the level of 0.05 is indicated by a
star.
Mutations G212A and E267A Alter Gating and
Voltage Dependence of ClC-5
To further evaluate differences in the behavior of the here
investigated Dent’s disease mutants, their characteristic current–
voltage relations were compared by plotting the transport
current amplitudes against the applied voltage. The so-obtained
quantitative data confirmed the preliminary observations that
current densities of both G212A and E267A ClC-5 are
significantly smaller than the one of WT ClC-5 in a broad range
of positive voltages (Figure 5A). Moreover, the current reduction
Frontiers in Physiology | www.frontiersin.org 6 May 2015 | Volume 6 | Article 159
Alekov Voltage-dependent gating and Dent’s disease
FIGURE 5 | Gating properties of the disease associated mutations
G212A and E267A ClC-5. (A) Averaged current–voltage relations
constructed by measuring the steady-state current amplitudes at the end of
voltage steps in the indicated range as depicted in Figures 3D–F for cells
expressing either WT (n = 5), G212A (n = 6) or E267A (n = 11) ClC-5.
Significant differences (for both mutants vs. WT ClC-5) at the level of 0.05 are
indicated as stars. (B) Ratio between the off-gating charge (Qoff ) and ionic
currents (I) at +165mV [n = 5.11, same cells as in (A)]. Significant differences
at the level of 0.05 are indicated as stars. (C) Voltage dependence of the
non-linear capacitances of WT and G212A and E267A ClC-5 determined by
using lock-in based impedance measurements. The curves for E267A and WT
ClC-5 exhibit the typical bell-shaped form and were fitted with the first
derivative of a standard Boltzmann function with the peak corresponding to
the half-maximal activation (E267A ClC-5 - V0.5 = 153± 2mV, n = 5; WT
ClC-5 - V0.5 = 128± 2mV, n = 5). The curve for mutation G212A did not
exhibit a peak within the investigated range and was not fitted. (D) Voltage
dependence of the activation of mutation G212A WT as obtained from gating
current measurements. The inset depicts a representative recording from WT
ClC-5 measured with short pulses. The encircled region is additionally
depicted enlarged to show the off-gating currents that were integrated to
obtain the gating charge Qoff. The red lines represent Boltzmann fits to the
data to obtain the half maximal voltage of activation (G212A and WT ClC-5,
respectively, V0.5 = 240± 10mV, n = 4 and V0.5 = 132± 6mV, n = 4).
for E267A was much higher (∼10-fold at +165mV) than the
expected ∼two-fold reduction extrapolated from the reduced
surface expression of this particular mutant (see Figure 4). In a
next step, the macroscopic differences of the gating currents of
the mutants were therefore also quantified by comparing their
gating charge and transport currents at +165mV (Figure 5B).
In particular, the gating charge was calculated by integrating the
surface under the gating currents (see insets in Figures 3D–F)
and the resulting value was divided by the ionic currents
measured at the same voltage to provide apparent gating
charge amplitudes for the investigated constructs. The analysis
showed that the activation of mutation E267A mobilizes more
gating charge than WT ClC-5 and that mutation G212A
exhibits the smallest gating charges from all investigated
constructs (Figure 5B). Based on the inverse dependency
between apparent gating charge and transport probability of ClC-
5, these differences suggest that the probability for undergoing
a silent non-transporting cycle (Grieschat and Alekov, 2012) is
decreased by mutation G212A but increased by mutation E267A.
Put in the context of the Dents’ disease pathophysiology, the
increased gating charge and accordingly the strongly reduced
probability for electrogenic cycling seems sufficient to explain
the smaller current amplitudes of mutation E267A ClC-5. This is
however in stark contrast to the reduced apparent gating charge
and increased open probability encountered for G212A ClC-
5. Viewed mechanistically, such increase does not correlate to
the actually measured higher endosomal pH in cells expressing
this mutant because it should lead to larger current amplitudes
and accordingly should favor stronger endosomal acidification.
A reduced surface expression or altered cellular localization
of this mutant were also dismissed as major defects based on
the obtained confocal images, the test of its relative surface
expression (see Figures 2–4) and previously published data
(Grand et al., 2009). It appeared therefore possible that further
gating alternations exist that reduce ion transport of G212A ClC-
5. Moreover, indications for such changes are readily notable
when observing the macroscopic current families recorded from
cells expressing G212A ClC-5 (Figure 3). In particular, the
spacing (or change of the amplitude) between the consequent
current traces in the whole cell currents of G212A is much
larger when compared to the other two investigated constructs.
To provide a quantitative measure for this observation, non-
linear capacitances weremeasured (Figure 5C) which are directly
related to the gating currents but also report the voltage
dependence of the activation of ClC-5 transport (Grieschat and
Alekov, 2014). The non-linear capacitances of WT ClC-5 present
themselves as a bell-shaped curve with a maximum at around
+130mV and can be described mathematically by a function
obtained as the first derivative of a standard one-step Boltzmann
activation. The peak of the curve corresponds to the voltage
of half-maximal activation of the process, i.e., the voltage at
which an apparent probability of 0.5 for ClC-5 to activate and
undergo a cycle with electrogenic ion transport is reached.
Performing analogous measurements on both Dent’s disease
mutants revealed different behavior. The non-linear capacitances
of E267A behaved in the expected way and provided a bell-shaped
curve. Their voltage dependence was slightly shifted to stronger
depolarized potentials, a change that will also lead to a reduction
of the expected ClC-5 ion transport for this particular mutant.
On the contrary, the non-linear capacitances of G212A did not
produce a peaked curve within the investigated voltage rage up
to+190mV but increased steeply with voltage starting at around
+150mV. This behavior suggests that the activation of G212A is
dramatically shifted to the right, but unfortunately also precludes
obtaining precise quantitative information on the magnitude
of this shift. The here used lock-in capacitance measurements
require applying AC sinus voltage with a frequency of 400Hz
that is superimposed on DC steps with voltages covering the
range of interest. Moreover, data of many sinus repetitions are
averaged in order to increase the precision of the measurements.
This requires using long voltage steps and precludes extending
the investigated voltage range because at high voltages the whole-
cell configuration becomes rapidly destabilized. To overcome
this difficulty, the voltage dependence of G212A was assessed
by analyzing the gating charge mobilized upon application of
depolarizing voltage steps. For the purpose of this analysis, the
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measurement protocol used to assess whole-cell currents and
gating charges of ClC-5 was optimized. In particular, very short
pulses (5-ms long) were used which preserved stable whole-
cell configuration for voltages as high as +350mV. Integrating
the off-gating currents obtained using this protocol provided
an estimate of the voltage dependence of G212A because the
gating charge saturated also for this mutant at high voltages
and accordingly could be described as a standard two-state
Boltzmann activation (Figure 5D). The analysis showed that
the activation of G212A is shifted by ∼100mV to the right
when compared to WT ClC-5 and measured under analogous
conditions. The encountered dramatic shift suffices to explain the
reduced transport activity and accordingly the reduced potency
of the mutant to support endosomal acidification (see Figure 2).
Mutation G212A Does Not Uncouple Proton from
Anion Transport
Both here investigated Dent’s mutations reside in the immediate
proximity of either the gating Gluext or the proton Gluin
glutamate (see Figure 1). Since neutralization of the negative
charge of these residues have been shown to completely uncouple
proton from anion transport in ClC-5 (Zdebik et al., 2008), the
possibility that the here investigated Dent’s disease mutation are
associated with similar defects has been also tested. Similarly
to previously described experiments (Alekov and Fahlke, 2009),
cells expressing both mutants were loaded with the pH-sensitive
dye BCECF trough a patch pipette under whole-cell patch
clamp and the intracellular alkalinization upon depolarizing
voltage steps was measured by ratiometric fluorometry. For
mutation E267A, no specific (that differed from measurements
in untransfected cells) proton flux could be detected even at
the highest investigated voltage of +140mV (data not shown).
This finding should however be taken with care because the
dramatically reduced transport probability of E267A might
bring its proton flux below the experimental resolution. In
contrast, significant voltage-dependent alkalinization could be
recorded in cells expressing G212A ClC-5 (Figure 6A) which
shows that similarly to WT ClC-5 (Grieschat and Alekov, 2012),
chloride transport is coupled to proton antiport in this mutant.
FIGURE 6 | Proton transport mediated by mutation G212A. (A)
Representative alkalinization recorded at different voltages in a cell transfected
with mutation G212A ClC-5 using ratiometric BCECF fluorometry. Lines
represent linear fits to the data and were used to provide the rates of
alkalinization 1pH/1t. (B) Averaged rates of alkalinization normalized to the
value measured at +140mV (n = 5). The red line represents the
current–voltage relation of G212A ClC-5 depicted in Figure 5A and
analogously normalized to the current measured at +140mV.
Moreover, superimposing the relative rates of intracellular pH
changes on the normalized current–voltage relation revealed that
they exhibit identical voltage dependence (Figure 6B). It seems
therefore that the shifted ClC-5 activation represents the major
defect underlying the pathophysiology of mutation G212A.
Discussion
Type 3 Dent’s Disease Mutations Impair Vesicular
Acidification
Several classifications of the various functional phenotypes
exhibited by the already described Dent’s disease mutations have
been created to group the individual mutations in accordance
to the identified functional defects (Smith et al., 2008; Lourdel
et al., 2012). Despite the partially overlapping characteristics of
the different mutations, their classification can be summarized
as follows: Class 1 mutations impair the processing and folding
of ClC-5 and are characterized by a pronounced retention in
the endoplasmic reticulum; Class 2 mutations induce a delay
or change in other way the protein processing which alters
the predominant cellular localization of the ClC-5 proteins
although they seem to leave the ER in a fully functional form;
Class 3 comprises a subset of mutations that seem to exhibit
high level of surface abundance when expressed in mammalian
cells or Xenopus laevis oocytes but to significantly reduced
electrogenic CLC transport. Remarkably, no clear correlation
between structural localization of the identified mutations and
their functional phenotype has been established until now.
Here, this problem has been addressed by investigating two
Class 3 mutations with the aim of providing insight into the
mechanism that underlie their reduced transport activity. The
first one, G212A, was already functionally tested by another
group and classified as Class 3 mutation (Grand et al., 2009).
The second one, E267A (Hoopes et al., 2004), has not been
functionally expressed until now. While surface expression for
this mutant was significantly reduced when compared to WT
ClC-5 (Figure 4, ∼two-fold), the much stronger ionic transport
reduction (∼10-fold) suggests that E267A also belongs or
shares an overlapping phenotype with the Class 3 group of
mutants. Fluorescence based measurements of vesicular acidity
showed that both mutations are significantly less efficient at
supporting endosomal acidification when compared to ClC-5
WT (Figure 2). These measurements at the cellular level provide
the mechanistic bases for the pathophysiology observed in the
affected patients and correlate neatly with the currently accepted
role of ClC-5 in the regulation of endosomal pH (Jentsch,
2008). It can be therefore concluded that similarly to mutations
belonging to the other classes, Class 3 mutations impair vesicular
acidification in kidney epithelia.
Correlation between Functional Phenotype and
Structural Localization of ClC-5 Mutations
Associated with Dent’s Disease
Electrophysiological and imaging investigations showed that
both here investigated mutants display mixed plasma membrane
and vesicular cellular localization and are capable of mediating
transport currents but that the amplitudes of these currents
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are dramatically changed (Figures 3–5). These results confirmed
previously published findings for mutation G212A (Grand
et al., 2009) and showed also that mutant E267A, that has
not been functionally investigated previously, causes even larger
transport reduction. However, the effects responsible for this
reduction are very different. Mutation G212A dramatically shifts
the activation of ClC-5 toward more depolarized potentials
by more than 100mV (Figures 5C,D). In essence, this means
that much higher voltages are required to activate this mutant.
Analyzing the amino acid sequence around this particular
mutation shows that it changes one of the two glycine residues
that surround the gating glutamate Gluext (E211 in ClC-5,
see Figure 1). This glutamate has been demonstrated to play
a crucial role for the CLC transport cycle. Crystallographic
studies have shown that depending on its protonation status, it
can undergo large conformational changes and occupy one of
the two upper-most of the three anion binding sites forming
the CLC anion selectivity filter or reside in the extracellular
solution (Dutzler et al., 2003; Feng et al., 2010). Such movements
require that the participating region possesses a relatively large
flexibility. It seems therefore that the role of the two glycines
on both side of of Gluext, one of which is altered by the
here investigated disease-causing mutation G212A, is to provide
this flexibility. Accordingly, the exchange of G212 for alanine
reduces this flexibility and impedes the the movement of the
Gluext from the external solution into the selectivity filter,
an effect that correlates with the significantly higher energy
required to activate ClC-5 (Figure 5). It is interestingly to
note that a mutation at the analogous position in CLCN1,
G233S (Richman et al., 2012), was associated with dominantly
inherited myotonia congenita. Mutations of G233 exert very
different effect on the gating of ClC-1 and lock the channel
in the open conformation at negative potentials (Fahlke et al.,
1997; Richman et al., 2012). This is in good correlation with
the findings reported here for G212A and reflects the fact
that, in contrast to ClC-5, Gluext in ClC-1 has to move out
of the selectivity filter upon activation in order to clear the
entrance of the selectivity filter and allow diffusive chloride
flux.
Mutation E267A also reduces the ClC-5 transport and shifts
its activation to the right. However, the shift is much smaller
when compared to G212A which contrasts the encountered
much larger current amplitude reduction (see Figures 3, 5).
Similar small shifts of the depolarization-induced activation have
been previously described for other ClC-5 mutations associated
with Dent’s disease and have been dismissed as causative for
the disease pathophysiology because they similarly did not
correlate with the observed current amplitude reduction (Gorvin
et al., 2013). The findings reported here provide explanation for
these phenomena by showing that an additional, very different
mechanism contributes to the current reduction observed for
mutation G267A. In particular, the apparent gating charge is
increased for this mutant which results in gating currents that
in comparison to ClC-5 WT are much larger when normalized
to the ion transport at the same voltage (Figure 5B). Previous
investigations have shown that charge movements in mammalian
CLC transporters originate from silent transport cycles that fail
to complete because of the insufficient delivery of intracellular
protons (Grieschat and Alekov, 2012, 2014; Guzman et al.,
2013). It appears therefore reasonable to conclude that mutation
E267A also impairs proton delivery and reduces in this way
the probability of ClC-5 to undergo a cycle associated with
electrogenic ion transport. This hypothesis is supported by the
structural proximity of E267 to the proton glutamate Gluin
(E268 in ClC-5, see Figure 1) that has been postulated to form
the entrance for intracellular protons. Moreover, it has been
previously postulated by others that the glutamate next to Gluin,
which corresponds to the here investigated position E267, also
represents a key player in the process of CLC proton transport.
In particular, two other CLC isoforms have been shown to
mediate coupled anion/proton transport despite the lack of a
negatively charged residue at the position of the proton glutamate
Gluin (Feng et al., 2010; Phillips et al., 2012). This led to
the hypothesis that the glutamate corresponding to the Dent’s
disease position E267 can take over the role of Gluin. The
data reported here substantiate this hypothesis and demonstrate
that the glutamate E267, similarly to the proton glutamate
Gluin, regulates the injection of intracellular protons into the
interior of ClC-5. This demonstrates therefore that glutamate
E267 represents a key element of the CLC transport cycle also
in the mammalian CLC transporters. It is interesting to note
that BCECF-based experiments failed to detect proton transport
for mutation E267A. It is therefore possible that in addition
to the reduced current amplitude, this mutation is associated
with partial transport uncoupling and permits limited anion
flux without the counterflux of protons. This hypothesis also
has its attractiveness because coupled anion/proton exchange
rather than chloride conductance has been recently shown to be
crucial for renal endocytosis (Novarino et al., 2010). If correct,
this would imply the existence of an additional differences
in the phenotype exhibited by the here investigated mutants.
As a consequence, proximal tubule cells expressing the E267A
mutant should exhibit more severe endocytosis defects. It appears
therefore interesting to address in the future the unclear transport
coupling stoichiometry of mutation E267A and the question
whether this is coupled to endosomal defects that resemble
the phenotype encountered in mice for which ClC-5 coupling
has been abolished by neutralizing the gating glutamate. The
uncoupling assumption should, however, be taken with care at
this point because it is also possible that due to the dramatically
reduced ClC-5 currents, proton transport of mutation E267A is
below the level of resolution of the technique used here to assess
intracellular alkalinization.
Physiological Implications
Voltage-dependent gating has been very early established as
an important determinant of the physiology of the channel
members of the CLC family (Jentsch, 2008). Surprisingly,
such correlation seems to be lacking for ClC-5. Recently, an
accelerated gating kinetics of the lysosomal Cl/H-exchanger ClC-
7/Ostm1 has been brought up as the reason for osteopetrosis
with gingival hamartomas in cattle (Sartelet et al., 2014).
The molecular mechanism of the observed gating alternations
have however not been explained in detail and a link to
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the voltage-dependence or proton transport of ClC-7 has
not been established. The here reported data show that
the voltage gating machinery of ClC-5 regulates endosomal
acidification. Moreover, it is obvious that not only the
depolarization activated gating by the gating glutamate Gluext
but also the gating associated with the proton glutamate
Gluin are important determinants of the physiological role of
ClC-5. Recently, profound differences in the behavior of three
mammalian CLC transporters—ClC-3, ClC-4, and ClC-5—have
been demonstrated. In particular, it was shown that the different
isoforms not only activate at different positive voltages but
also exhibit different absolute open probabilities, i.e., different
probabilities to undergo a conformational cycle associated with
electrogenic ion transport and accordingly different gating
charge amplitudes (compared to the corresponding ion currents).
However, the physiological importance of these differences
has not been demonstrated yet but has been postulated only
theoretically. (Guzman et al., 2013) The experimental data
reported here correlate molecular defects in ClC-5 that underlie
the human renal condition Dent’s disease with defects in both
gating processes and establish therefore their physiological
importance. It seems therefore that the gating characteristics
of CLC transporters and their evolutionary optimization
are an important determinant of the cellular role of these
proteins.
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